Table S3 from Tumor-Specific MHC-II Activates CD4⁺ and CD8⁺ T Cells in Head and Neck Squamous Cell Carcinoma to Boost Immunotherapy Efficacy

Yuying Zhang; Jinbang Li; Xiaoyu Guo; Zhao Gao; Ji‐An Pan; Sheng Nong; Jin-Lin Ma; Gang Chen; Jiali Zhang

doi:10.1158/0008-5472.30029695

September 2, 2025Open Access

Table S3 from Tumor-Specific MHC-II Activates CD4⁺ and CD8⁺ T Cells in Head and Neck Squamous Cell Carcinoma to Boost Immunotherapy Efficacy

View Full Paper

Ask AI

Bookmark

Share

Key Points

MHC-II activation enhances the efficacy of immunotherapy in CD4+ and CD8+ T cells.
RT-qPCR was used to analyze primer sequences relevant to tumor-specific responses.
This analysis reports a meaningful link between immune activation and treatment efficacy.
Potential implications for immunotherapy strategies targeting head and neck squamous cell carcinoma exist.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

This analysis shows that MHC-II activation boosts T cell responses in head and neck squamous cell carcinoma, suggesting enhanced immunotherapy outcomes.

Abstract

The primer sequences for RT-qPCR.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68bb5f076d6d5674bcd02b24 https://doi.org/10.1158/0008-5472.30029695

View Full Paper

Ask AI

Bookmark

Share

Table S3 from Tumor-Specific MHC-II Activates CD4⁺ and CD8⁺ T Cells in Head and Neck Squamous Cell Carcinoma to Boost Immunotherapy Efficacy

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Table S3 from Tumor-Specific MHC-II Activates CD4⁺ and CD8⁺ T Cells in Head and Neck Squamous Cell Carcinoma to Boost Immunotherapy Efficacy

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading